AS

Ashish Singh

Active Director Director DIN 09015277
DIN 09015277 First appointment Dec 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2020
Shareholding value •••• Premium profile

About Ashish Singh

Data last updated:

Ashish Singh is a Director at Meditatav Pharma Private Limited (since 2020). The company operates in Chemicals. Meditatav Pharma Private Limited reported revenue of ₹2.2 Lakh (FY 2022).

DIN 09015277
Primary Designation Director
Industry Chemicals
First Appointment 30 Dec 2020
Oldest Company Age 5 yrs
Largest company Meditatav Pharma Private Limited · ₹2.2 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Meditatav Pharma Private Limited U24230UP2020PTC139877
Director30 Dec 20202020₹2.2 Lakh (FY 2022)Active

Board colleagues of Ashish Singh

Directorship timeline

Open interactive timeline →
Meditatav Pharma Private Limited
Premium access

Shareholding and investment profile for Ashish Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashish Singh

Ashish Singh currently holds 1 directorship: Meditatav Pharma Private Limited (Director, since 30 Dec 2020, revenue ₹2.2 Lakh (FY 2022)).

Ashish Singh was first appointed on 30 Dec 2020 as Director at Meditatav Pharma Private Limited.

The current boards of Ashish Singh's companies include Gaurav Singh (Meditatav Pharma Private Limited), Purushottam Pratap Singh (Meditatav Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available